Core Viewpoint - Beiyinmei's stock price has shown significant fluctuations, with a year-to-date increase of 53.68% and a recent decline over the past 60 days, indicating volatility in market performance [2]. Financial Performance - For the period from January to September 2025, Beiyinmei reported a revenue of 2.033 billion yuan, a year-on-year decrease of 2.59%, while the net profit attributable to shareholders increased by 48.07% to 106 million yuan [2]. - The company has cumulatively distributed 961 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of November 3, Beiyinmei's stock price was 6.47 yuan per share, with a trading volume of 1.47 billion yuan and a market capitalization of 6.988 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" 24 times this year, with the most recent net purchase on August 7 amounting to 17.7676 million yuan [2]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 3.24% to 147,900, with an average of 7,302 circulating shares per person, a decrease of 3.14% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Tianhong Zhongzheng Food and Beverage ETF, with both increasing their holdings [3]. Market Position - Beiyinmei operates primarily in the infant food and milk-based nutrition sector, with its main revenue sources being milk powder (89.20%), followed by other categories [2]. - The company is classified under the food and beverage industry, specifically in the dairy products segment, and is involved in various concept sectors such as new retail and cross-border e-commerce [2].

Core Viewpoint - TianKang Biological experienced a stock price increase of 2.03% on November 3, reaching 7.53 CNY per share, with a total market capitalization of 10.28 billion CNY [1] Company Overview - TianKang Biological Co., Ltd. is located in Urumqi, Xinjiang, and was established on December 28, 2000, with its stock listed on December 26, 2006 [1] - The company specializes in the production and sales of biological vaccines for livestock and poultry, feed, plant protein, breeding of breeding pigs, pig farming, slaughter processing, and meat product sales [1] - The revenue composition includes: 32.20% from pig farming, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, and 3.40% from other sources [1] Financial Performance - For the period from January to September 2025, TianKang Biological achieved an operating income of 13.61 billion CNY, representing a year-on-year growth of 4.00%, while the net profit attributable to shareholders decreased by 27.20% to 412 million CNY [2] - The company has distributed a total of 1.89 billion CNY in dividends since its A-share listing, with 598 million CNY distributed over the past three years [3] Shareholder Information - As of October 20, 2025, the number of shareholders decreased by 1.20% to 59,800, while the average number of circulating shares per person increased by 1.21% to 22,815 shares [2] - Notable institutional holdings include: Guotai Zhongzheng Livestock Breeding ETF as the fifth largest shareholder with 24.30 million shares, an increase of 8.75 million shares; Hong Kong Central Clearing Limited as the seventh largest shareholder with 15.03 million shares, a new entry; and Jiashi Agricultural Industry Stock A as the eighth largest shareholder with 13.91 million shares, an increase of 3.61 million shares [3]

Group 1 - The 8th China International Import Expo (CIIE) will be held in Shanghai from November 5 to 10, showcasing innovations across various sectors and providing global companies with opportunities to expand into the Chinese market [1] - Major companies like L'Oréal and Panasonic will present numerous global and China debuts of innovative products, highlighting the event's focus on cutting-edge trends and technologies [1] - L'Oréal will showcase its strongest lineup of debuts, including three new brands making their Asian debut and 19 new products, emphasizing the importance of CIIE for global engagement [1] Group 2 - The CIIE will feature new consumer themes and trends, including a focus on the "silver economy" in the medical exhibition area, showcasing products for the elderly and sleep recovery technologies [2] - A new pet-themed exhibition area will be introduced, reflecting the growing "pet economy" in China [2] - The CIIE is increasingly recognized as a global public good, with special zones for products from least developed countries, promoting zero-tariff benefits for these nations to access the Chinese market [2]

Group 1: Financial Performance - The main reason for the quarter-on-quarter growth in Q3 2025 is the decrease in raw material prices and international shipping costs, along with increased sales [2] - There is a risk of raw material prices rebounding due to international political and economic conditions, trade policies, and market supply-demand relationships [2][3] - The international shipping costs have shown fluctuations in Q3 2025, with potential risks of price increases in the future [3] Group 2: Production Capacity and Expansion - The Malaysian factory has a designed capacity of 60,000 tons per year and is expected to be completed and operational by Q4 2025 [4] - The Polish factory experienced losses in the first half of 2025, but it is a strategic investment for long-term development and gaining customer trust in Europe [5] - The company plans to optimize production across its global factories to meet European demand while considering geopolitical factors [5] Group 3: Industry Growth Prospects - The market for medical hot melt adhesives is stable, with annual growth driven by increasing demand from various demographics, including the elderly and pets [6][7] - Emerging markets present significant growth potential due to low penetration rates despite large populations [7] - The company aims to expand its market share in the medical hot melt adhesive sector while exploring other application areas to create new growth opportunities [7]

Investment Rating - Industry Rating: Outperform the market (maintained rating) [11] Core Views - The agricultural sector is experiencing a mixed performance with significant opportunities in various sub-sectors, particularly in pig farming, cattle, pets, poultry, and planting industries. The report emphasizes the importance of focusing on leading companies with strong profitability and market positioning [3][4][5][6][8][26]. Summary by Relevant Sections 1. Pig Farming Sector - The decline in pig prices has led to a divergence in profitability among companies, highlighting the need to focus on expected differences in the pig farming sector. The average selling price of pigs in Q3 2025 was between 13-14 CNY/kg, down from 14-15 CNY/kg in H1 2025 [3][15]. - Key companies to watch include leading players like Muyuan Foods and Wens Foodstuff, with valuations at historical low levels [3][16]. 2. Cattle Sector - The raw milk price is stabilizing, while the beef cattle sector may be entering a super cycle. The average price for beef cattle in Q3 2025 was 25.88 CNY/kg, up 2.34% from the previous quarter [4][17]. - Companies with mother cow resources or those adopting a "milk-meat linkage" model are expected to have stronger profitability [4][18]. 3. Pet Sector - The pet economy is thriving, with domestic brands rapidly rising. Major pet food companies reported revenues of 4.737 billion CNY for Guibao Pet and 3.860 billion CNY for Zhongchong Co., with growth rates of 29% and 21% respectively [5][19]. - Recommended companies include Guibao Pet, Zhongchong Co., and Petty Co. [5][20]. 4. Poultry Sector - The white chicken segment is under pressure, with a focus on the need for improved breeding practices. The average price for white chicken was reported to be 3.5 CNY/kg, with a slight increase [6][21]. - The yellow chicken market is expected to see price recovery due to seasonal demand, with companies like Lihua and Wens showing improved performance [6][23]. 5. Planting Sector - The seed industry is anticipated to recover, with a focus on the commercialization of genetically modified corn. Leading companies in the seed sector include Longping High-Tech and Dabeinong [8][26]. - The report emphasizes the importance of agricultural technology and innovation in enhancing competitiveness [8][27]. 6. Feed and Animal Health Sectors - The feed sector has shown revenue and profit growth among leading companies, with Haida Group reporting a revenue increase of 13.24% [8][28]. - The animal health sector is facing challenges due to competition, but there are opportunities for innovation in vaccine development [8][32].

Group 1 - The eighth China International Import Expo (CIIE) will be held in Shanghai from November 5 to 10, showcasing global innovations and providing opportunities for companies to expand into the Chinese market [1][2] - Major companies like L'Oréal and Panasonic will present a range of global and China debuts of innovative products, highlighting the importance of the expo in fostering innovation and collaboration across industries [1][2] - The expo will feature new themes and trends, including a focus on the "silver economy" in the medical sector and a dedicated pet-themed exhibition area, reflecting the evolving consumer preferences in China [2][3] Group 2 - The CIIE is increasingly recognized as a global public good, with initiatives to support products from least developed countries, allowing them to benefit from zero-tariff treatment in the Chinese market [2] - Companies from Madagascar, such as the Madagascar Livestock Company, are participating for the first time, showcasing their products in China, which indicates the growing international interest in the Chinese market [3]

Core Insights - The 8th China International Import Expo (CIIE) will be held from November 5 to 10 in Shanghai, showcasing global innovations and providing opportunities for companies to expand in the Chinese market [1][2] - The event will feature numerous global and China debuts of innovative products, highlighting the latest technological advancements across various industries [1][2] Group 1: Company Participation - L'Oréal will present its strongest lineup of debuts, including three new brands and 19 new products, emphasizing the importance of CIIE for global trends and innovation [1] - Panasonic will unveil its AI strategy for China and showcase globally innovative products, reflecting China's role as a hub for innovation and engineering [1][2] Group 2: Market Trends - The expo will highlight new consumer trends, including a focus on the "silver economy" with products for the elderly and a dedicated pet-themed area to showcase the pet economy [2] - The sports and fitness sector is gaining traction, with brands like Lululemon expressing confidence in the long-term potential of the Chinese market [2] Group 3: Global Collaboration - CIIE is increasingly recognized as a global public good, with new initiatives to support products from least developed countries, enhancing their access to the Chinese market [2] - Madagascar's participation marks a significant step, with the introduction of frozen goat meat products in Chinese supermarkets following their debut at the expo [3]

Core Insights - The Daxing District's Panggezhuang Watermelon Town is positioned as a "happy leisure" destination, focusing on the pet economy and agricultural technology, aiming to create a benchmark for integrated urban and rural commercial development [2] - The 2025 Flower and Pet Season will commence on November 7, serving as a critical milestone for industry implementation [2] Group 1: Event and Activities - The Flower and Pet Season includes three major activities that contribute to economic empowerment: - The Fourth Pet Industry Technology Innovation and Investment Forum will be held in Northern China, providing a platform for capital connection to enhance the operational efficiency of pet tech enterprises [2] - The JD.com Watermelon Town Pet Carnival will engage pet-friendly hotels and homestays, covering all scenarios of "pet-inclusive consumption" to stimulate family consumer spending [2] - The Longhua Street Flower Parade will connect corporate displays with public participation, reinforcing the commercial atmosphere of the "flower and pet economy" [2] Group 2: Key Projects and Economic Impact - The Longxi Weijing Hotel is the first pet-friendly hotel in Daxing, filling a gap in themed accommodation in the region [3] - The Jingnan Agricultural Technology Park leverages state-owned capital to develop both agricultural technology and the pet economy, attracting high-end agricultural tech enterprises [3] - The Beijing International Flower Modern Industry Park is establishing a full industrial chain trade platform for flowers, promoting cross-border floral economy, benefiting from the Daxing Airport hub [3] - The organizers aim to activate the commercial potential of the town through the Flower and Pet Season, attracting resources from the industry chain to inject new momentum into the high-quality economic development of Daxing [3]

Core Insights - The eighth Royal Veterinarian Conference, organized by Royal Canin (Shanghai) Co., Ltd. and the Chinese Veterinary Association, focused on key topics such as breakthroughs in pet diagnosis and nutrition, and advanced hospital management, promoting sustainable development in China's pet healthcare industry [1] Group 1: Industry Development - The pet economy in China is experiencing robust growth, with a shift towards comprehensive health management and specialized services in pet medical care [1] - Precision nutrition, based on individual health needs and physiological characteristics of pets, plays a crucial role in disease prevention, recovery promotion, and quality of life enhancement [1] Group 2: Company Initiatives - Royal Canin has been active in China for 30 years, continuously introducing cutting-edge precision nutrition solutions and supporting the growth of veterinary professionals through various educational activities [1] - The company aims to further collaborate with veterinarians to advance the development of the pet economy in the future [1] - A presentation titled "Royal Nutrition New Path: Resonance of Precision Value" was delivered at the conference, reflecting on Royal Canin's deep engagement in China and future nutritional strategy [1]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The company's performance for the first three quarters of 2025 met expectations, with a revenue of 1.025 billion yuan, reflecting a year-on-year growth of 10% [6] - The core IP capabilities are strong, with significant growth in key events such as the World Artificial Intelligence Conference and the Shanghai Marathon, which are expected to enhance revenue streams [6] - The company has a robust shareholder return strategy, with a dividend payout ratio of 76.32% of the net profit for the first half of 2025, indicating confidence in future performance [6] Financial Data and Profit Forecast - Total revenue for 2025 is projected at 1.694 billion yuan, with a year-on-year growth rate of 3.1% [5] - The net profit attributable to the parent company is expected to be 305 million yuan for 2025, showing a slight decrease of 0.6% year-on-year [5] - The earnings per share (EPS) for 2025 is estimated at 0.41 yuan, with a projected price-to-earnings (PE) ratio of 27 [5] Business Strategy - The company is expanding its market presence through various collaborations and strategic partnerships, enhancing its national and international footprint [6] - It is also diversifying into new sectors, such as the pet economy, and leveraging its core IP to transition into a comprehensive service provider in the AI field [6] - The company has established a professional subsidiary to operate year-round services related to the World Artificial Intelligence Conference, aiming to broaden its revenue sources [6]